companydata.dkcompanydata.dk

CanNordic a/s: Financial statements 2022

CVR: 33871902

Source: annual report 2022, Danish Business Authority

01/10/2021 – 30/09/2022

CanNordic a/s (CVR 33871902) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 502,674 and a net result of DKK -4,299,257 compared with DKK 1,480,251 the year before. That is a decrease of 79.4% compared with the year before. Equity in the 2022 report amounted to DKK 640,767. The solvency ratio was 3%. The company had 5 employees in the financial year.

Gross Profit
DKK 502,674
Profit/Loss
DKK -4,299,257
Equity
DKK 640,767
Total Assets
DKK 21,373,261
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-503 t.-4.3 mio.641 t.5
20213.2 mio.2.4 mio.1.5 mio.1.9 mio.4
2020-775 t.-46 t.47 t.2
2019-211 t.-178 t.-1.8 mio.-
2018-579 t.200 t.-1.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CanNordic a/s

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Bo Erik Lennart Unéus leaves the board of CanNordic a/sOct 25, 2022

As of October 25, 2022, Bo Erik Lennart Unéus has left the board of directors of CanNordic a/s.

Alexandre Fevre joins the board of CanNordic a/sFeb 9, 2022

As of February 9, 2022, Alexandre Fevre has joined the board of directors of CanNordic a/s.

CanNordic a/s: The 2021 annual report is outJan 3, 2022

CanNordic a/s has published its annual report for 2021. Revenue came to DKK 3,156,907, and the net result was DKK 1,480,251.

About CanNordic a/s

CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.

Source: annual report 2025, Danish Business Authority